Verastem (VSTM) - NASDAQ
Company Description
Verastem, Inc. is a clinical biopharmaceutical company, which is focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells. The company is developing small molecule inhibitors of signaling pathways which includes Focal Adhesion Kinase FAK, PI3K/mTOR... More
Sector: Healthcare
Industry: Biotechnology
Country: United States